• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares Russell 2000 BuyWrite ETF (NY:IWMW)

38.97 +0.23 (+0.59%)
Official Closing Price Updated: 8:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,441
Open 39.02
Bid (Size) 33.05 (100)
Ask (Size) 49.62 (100)
Prev. Close 38.74
Today's Range 38.70 - 39.04
52wk Range 34.29 - 46.05
Shares Outstanding N/A
Dividend Yield 21.71%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Rigetti Computing Stock Draws Retail Buzz After Quantum Timeline Slips And Insider Sale Surfaces ↗
January 02, 2026
Via Stocktwits
News headline image
WULF Stock Rises 3% Pre-Market After Keefe More Than Doubles Price Target ↗
December 31, 2025
Keefe Bruyette upgraded TeraWulf to an ‘Outperform’ rating from ‘Market Perform’, citing its optimism on the company’s high-performance computing transition. 
Via Stocktwits

Performance

YTD
N/A
N/A
1 Month
-0.7%
-0.7%
3 Month
-3.6%
-3.6%
6 Month
-0.2%
-0.2%
1 Year
-11.6%
-11.6%

More News

Read More
News headline image
Verastem Oncology Stock Drops After Hours After Discontinuing A Clinical Trial In Lung Cancer ↗
December 29, 2025
Via Stocktwits
Topics Supply Chain
News headline image
SELLAS Life Sciences Group Stock Soars As It Nears Final Analysis In Cancer Study ↗
December 29, 2025
Via Stocktwits
Topics Death
News headline image
Tonix Pharmaceuticals To Meet With FDA In 2026 To Advance Experimental Lyme Disease Prevention Drug ↗
December 29, 2025
Via Stocktwits
Why Are Retail Traders Going Gaga Over BioCryst Pharma Stock Today? ↗
December 12, 2025
Via Stocktwits
Mirum Stock Slips On $820M Bluejay Deal — But Wall Street Calls The Hepatitis Drug Seal A 'Steal' ↗
December 08, 2025
Via Stocktwits
American Eagle's Gen Z Playbook Is Working — Sydney Sweeney And Travis Kelce Might Only Be The Opening Act ↗
December 03, 2025
Via Stocktwits
News headline image
Why Is UUUU Stock Rising Today? ↗
December 29, 2025
Via Stocktwits
Topics Government World Trade
News headline image
Biohaven Stock Slumps After Hours As Failed Depression Study Adds To A Brutal 2025 — Retail Eyes Epilepsy And Obesity Catalysts ↗
December 24, 2025
Via Stocktwits
News headline image
Edgewise Therapeutics Stock Jumps After Trial Update For Genetic Heart Disease — Wall Street Eyes A Potential Standout ↗
December 24, 2025
Via Stocktwits
News headline image
SLS Stock Has Risen 78% In A Month — What’s The Retail Buzz About? ↗
December 24, 2025
Via Stocktwits
News headline image
After A Sharp Rally In 2025, Ramaco Is Doubling Down With $100M Share Buyback ↗
December 24, 2025
Via Stocktwits
Archer Aviation Stock Jumps On Tech Deal With Karem For Military Aircraft — Retail Seeks Tangible Progress ↗
December 02, 2025
Via Stocktwits
Vanda Pharmaceuticals Says FDA Will Take More Time To Decide On Tradipitant Clinical Hold Re-Review ↗
November 28, 2025
Via Stocktwits
News headline image
EchoStar’s SpaceX Stake Is Driving UBS, Citi Price Target Revisions ↗
December 23, 2025
Via Stocktwits
News headline image
Cytokinetics Wins First FDA Approval For Heart Disease Drug — Why Is Wall Street Still Cautious? ↗
December 19, 2025
Via Stocktwits
News headline image
Disc Medicine Stock Slides After FDA Fast-Track Approval Doubts Surface — Wall Street Calls It An ‘Overreaction’ ↗
December 19, 2025
Via Stocktwits
Rezolve AI Stock Shot Up Over 27% Today — How Did Microsoft, Google Help Double 2025 ARR Expectations? ↗
December 16, 2025
Via Stocktwits
Topics Artificial Intelligence
News headline image
Why Is GLSI Stock Rising Today? ↗
December 15, 2025
Via Stocktwits
News headline image
Anavex Stock Slides After Hours On EMA Panel’s Negative Alzheimer’s Drug Opinion — Retail Traders Talk Buyout Potential ↗
December 12, 2025
Via Stocktwits
News headline image
Rhythm Pharmaceuticals Stock Rises After Positive Study Data For Setmelanotide In Treating Genetic Disorder ↗
December 11, 2025
Via Stocktwits
News headline image
Compass Diversified Stock Plunges On ‘Most Significant Loss’ After Fraud Forces Removal Of Three Years Of Financials ↗
December 05, 2025
Via Stocktwits
Topics Fraud
News headline image
Capricor Therapeutics Stock Sparks Retail Frenzy As Traders Hail ‘Best Data’ Ahead Of DMD Data Readout ↗
December 01, 2025
Via Stocktwits
News headline image
Kohl’s Traders Just Got The CEO They Wanted — And the Stock’s Weekly Breakout Says It All ↗
December 01, 2025
Via Stocktwits

Frequently Asked Questions

Is iShares Russell 2000 BuyWrite ETF publicly traded?
Yes, iShares Russell 2000 BuyWrite ETF is publicly traded.
What exchange does iShares Russell 2000 BuyWrite ETF trade on?
iShares Russell 2000 BuyWrite ETF trades on the New York Stock Exchange
What is the ticker symbol for iShares Russell 2000 BuyWrite ETF?
The ticker symbol for iShares Russell 2000 BuyWrite ETF is IWMW on the New York Stock Exchange
What is the current price of iShares Russell 2000 BuyWrite ETF?
The current price of iShares Russell 2000 BuyWrite ETF is 38.97
When was iShares Russell 2000 BuyWrite ETF last traded?
The last trade of iShares Russell 2000 BuyWrite ETF was at 01/02/26 08:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap